Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-L1 Expression”

101 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 101 results

Not applicableLooking for participantsNCT07422779
What this trial is testing

Immunotherapy Efficacy and PD-L1 as a Predictive Biomarker in Metastatic Melanoma in Slovenia

Who this might be right for
Metastatic MelanomaSkin Cancer
Institute of Oncology Ljubljana 100
Not applicableUnknownNCT05008796
What this trial is testing

PD-L1 Expression on CTCs in HNSCC Patients Underwent Curative CCRT

Who this might be right for
Head and Neck Squamous Cell CarcinomaCirculating Tumor Cell
Chang Gung Memorial Hospital 50
Not applicableStudy completedNCT03989297
What this trial is testing

PD-L1 and BRAF Expression in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Kiang Wu Hospital 104
Not applicableStudy completedNCT03997747
What this trial is testing

Cancer Genome Study Using Samples From Patients Treated on Clinical Trial SHR1020-SHR-1210-II-OS

Who this might be right for
Osteosarcoma
Peking University People's Hospital 38
Not applicableStudy completedNCT02475889
What this trial is testing

Hepatic RFA Increases T Cell Infiltraion and PD-L1 Expression in Primary Colorecatl Cancer

Who this might be right for
Colorectal Cancer
The First People's Hospital of Changzhou 78
Not applicableLooking for participantsNCT07279402
What this trial is testing

TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%

Who this might be right for
NSCLC Stage IVPD-L1 Gene MutationAtezolizumab+1 more
Antalya Training and Research Hospital 150
Not applicableStudy completedNCT05129462
What this trial is testing

Consistency of PD-L1 Detecting Method Between E1L3N and 22C3 Monoclonal Antibodies in NSCLC Patients

Who this might be right for
Non Small Cell Lung Cancer
Hunan Province Tumor Hospital 52
Testing effectiveness (Phase 2)UnknownNCT05203276
What this trial is testing

Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC

Who this might be right for
Lung Neoplasms
The First People's Hospital of Lianyungang 40
Testing effectiveness (Phase 2)UnknownNCT03503786
What this trial is testing

Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
National Cancer Institute, Naples 125
Testing effectiveness (Phase 2)Ended earlyNCT03417882
What this trial is testing

GRN-1201 With Pembrolizumab in Subjects With Metastatic PD-L1+ NSCLC

Who this might be right for
Metastatic NSCLC
BrightPath Biotherapeutics 20
Not applicableUnknownNCT05228808
What this trial is testing

Immunohistochemical Expression of PD-L1 in Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Sohag University 50
Not applicableUnknownNCT04436406
What this trial is testing

PD-L1 Expression in Cancer (PECan Study).

Who this might be right for
Non-small Cell Lung CancerMelanoma
Guy's and St Thomas' NHS Foundation Trust 30
Not applicableStudy completedNCT02827344
What this trial is testing

PDL-1 Expression on Circulating Tumor Cells in Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
University Hospital, Toulouse 216
Not applicableStudy completedNCT03073902
What this trial is testing

The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.

Who this might be right for
NSCLC
Xinqiao Hospital of Chongqing 80
Not applicableStudy completedNCT03748901
What this trial is testing

PD-L1 Expression in Japanese Renal Cell Carcinoma Patients

Who this might be right for
Renal Cell Carcinoma
Chugai Pharmaceutical 830
Not applicableNot Yet RecruitingNCT07051928
What this trial is testing

Study of Atezolizumab in Advanced Non-oncogene-addicted NSCLC With PD-L1 ≥50%, Including Longitudinal c-FLIP Assessment in Monocytic MDSCs.

Who this might be right for
Non Small Cell Lung Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 107
Testing effectiveness (Phase 2)Study completedNCT02859454
What this trial is testing

Avelumab for People With Recurrent Respiratory Papillomatosis

Who this might be right for
Recurrent Respiratory PapillomatosisJuvenile Laryngeal PapillomaLaryngeal Papilloma, Recurrent+2 more
National Cancer Institute (NCI) 13
Not applicableUnknownNCT05692895
What this trial is testing

PDL1 In Primary Colorectal Carcinoma and Its Prognostic Impact

Who this might be right for
PDL1- Colorectal Carcinoma
Sohag University 60
Early research (Phase 1)Looking for participantsNCT07096882
What this trial is testing

SDTM001 Injection as Adjuvant Therapy for NSCLC Patients After Radical Surgical Resection

Who this might be right for
Non-Small Cell Lung Cancer
Cytocraft Biopharmaceutical Co., Ltd. 22
Large-scale testing (Phase 3)Looking for participantsNCT06767514
What this trial is testing

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Who this might be right for
Non-Small Cell Lung Cancer
Summit Therapeutics 780
Next Page